Blood retinal and blood aqueous barriers in diabetics by fluorophotometry
- PMID: 2743854
- DOI: 10.1007/BF00155129
Blood retinal and blood aqueous barriers in diabetics by fluorophotometry
Abstract
The permeability of the blood retinal barrier (PBRB) and the diffusion coefficient into the anterior chamber (kd) in 20 insulin dependent (ID) and in 11 non-insulin dependent (NID) diabetics with various degrees of retinopathy were determined by fluorophotometry with a 25% accuracy. The difference of PBRB and the kd values between the NID and the ID patients was not significant (p greater than 0.05 and p greater than 0.22). The mean PBRB and the mean kd values differed significantly from those of a healthy population (p less than 0.0013 and p = 0.025). A significant correlation was established between PBRB and diabetes duration (r = 0.55; p less than 0.01) but not between PBRB or kd values and metabolic control (HbAl) (p greater than 0.5) or creatinine clearance (p greater than 0.5). The time integrals of unbound plasma fluorescein in the diabetics between the time of injection and 1 hour later were comparable with those of healthy controls. The difference between the mean PBRB value of diabetics with advanced retinopathy and that of a healthy population was significant (p less than 0.003) but the difference for the mean values of diabetics with no or minimal background retinopathy was not (p greater than 0.2), indicating that PBRB values do not increase to an abnormal level while signs of diabetic retinopathy are absent on fluorescein angiography.
Similar articles
-
Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.Ger J Ophthalmol. 1993 Aug;2(4-5):202-6. Ger J Ophthalmol. 1993. PMID: 8220099
-
The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.Ophthalmic Res. 1995;27 Suppl 1:116-23. doi: 10.1159/000267856. Ophthalmic Res. 1995. PMID: 8577448
-
Blood-retinal and blood-aqueous barrier permeability, lens autofluorescence and transmission in insulin-dependent diabetic youngsters.Graefes Arch Clin Exp Ophthalmol. 1989;227(1):26-9. doi: 10.1007/BF02169820. Graefes Arch Clin Exp Ophthalmol. 1989. PMID: 2920905
-
Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy.Doc Ophthalmol. 1992;80(2):183-8. doi: 10.1007/BF00161244. Doc Ophthalmol. 1992. PMID: 1425133
-
Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.Acta Ophthalmol Suppl (1985). 1993;(211):1-52. Acta Ophthalmol Suppl (1985). 1993. PMID: 8318868 Review.
Cited by
-
Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.Doc Ophthalmol. 1994;87(4):355-65. doi: 10.1007/BF01203344. Doc Ophthalmol. 1994. PMID: 7851219 Clinical Trial.
-
Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.Graefes Arch Clin Exp Ophthalmol. 1997 Oct;235(10):639-46. doi: 10.1007/BF00946940. Graefes Arch Clin Exp Ophthalmol. 1997. PMID: 9349948
-
Diffusion coefficient through the blood-aqueous barrier using a standard protocol.Br J Ophthalmol. 1996 Apr;80(4):356-62. doi: 10.1136/bjo.80.4.356. Br J Ophthalmol. 1996. PMID: 8703890 Free PMC article.
-
Evaluation of diabetic retinopathy by fluorophotometry. European concerted action on ocular fluorometry.Int Ophthalmol. 1998-1999;22(2):97-104. doi: 10.1023/a:1006132908679. Int Ophthalmol. 1998. PMID: 10472769 Clinical Trial.
-
An unbiased method for evaluating the genome-wide specificity of base editors in rice.Nat Protoc. 2021 Jan;16(1):431-457. doi: 10.1038/s41596-020-00423-y. Epub 2020 Dec 21. Nat Protoc. 2021. PMID: 33349703
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical